GAIA’s mHealth products have demonstrated their clinical benefit in numerous RCTs. Our products meet all regulatory and data protection requirements in the EU and US.


GAIA is a European pioneer in mobile health (mHealth), launching its first programme successfully in 2001.

Our mission: Designing and developing software-based medical devices that offer physicians, therapists and patients the same effect sizes, similar safety profiles, and equal levels of convenience as found in well-developed pharmaceutical solutions.

Our multidisciplinary expert teams cover all competencies required to develop, launch and maintain top-of-class products for major markets: Experienced physicians and psychotherapists, clinical scientists experienced in orchestrating Phase II & III trials, IT and software engineers, regulatory affairs experts as well as market access specialists.

Our pipeline: the next generation in mHealth

One of our most researched products is deprexis®, the online programme for the treatment of depression. deprexis® has been shown to effectively reduce symptoms of depression in 5 randomized controlled trials (RCTs) as well as in real-life clinical settings, with effect sizes similar to those of antidepressants. For more information, please visit

Our current R&D pipeline with 7,000 patients in clinical trials covers a wide range of phase II and phase III next generation mHealth programmes, for conditions such as borderline personality disorder (priovi®), generalized anxiety disorder / panic disorder / social phobia (velibra®), fatigue in multiple sclerosis (elevida®), or compliance support (covivio®), among others. For more detailed information regarding our pipeline or requests for research and development partnerships, please contact us directly via mail or phone.


Our expert system technology platform broca® forms the backbone of more than 70 mHealth training, education and therapeutic intervention programmes developed and implemented to date. Started as a joint venture with the Airbus group, broca® has set healthcare industry benchmarks for individualized web based solutions. Our programmes simulate 1:1 coaching, training or therapy sessions, in which a virtual expert and a user interact intensively to achieve a particular goal. Similar to a chess computer, broca® programmes facilitate rapid learning and deep skill acquisition in a dynamic and individual flow. The programmes engage users continuously in interactive exercises and guide them, step-by-step, towards specific learning goals and therapeutic targets.

Flexible for the future

The latest version of our broca® 4.0 software affords the flexibility to run our highly individualised programs on nearly all web-compatible devices. Consistent with a “quantified-self” approach, we can now capture and visually display a host of performance parameters, assessed either directly within the systems or via interfaces with fitness wristbands, medical devices or other applications. Our broca® 4.0 software enables us to integrate such parameters in our individualised, dialogue-based programs, allowing us to produce even more targeted and custom-tailored interventions. The new platform is CE-certified, FDA approvable and offers many options for health care professionals wishing to monitor and support their patients’ program use.

Services: Consulting by the leaders

Not only do we develop our own new and innovative products, but we also share our expertise and experience with selected customers – offering a broad variety of services and consulting relating to mHealth, e.g. risk assessment for your mHealth products/Apps, CE-certification, cloud computing and social data security as well as “big data” management and analysis.